JP Morgan Chase’s Agile Therapeutics AGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $15K | Buy |
|
|||||
|
2023
Q3 | $8.36K | Buy |
|
|||||
|
2023
Q2 | $15 | Sell |
|
|||||
|
2023
Q1 | $0 | Hold |
|
|||||
|
2022
Q4 | $0 | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $0 | Buy |
|
|||||
|
2022
Q1 | – | Hold |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $4K | Sell |
|
|||||
|
2021
Q2 | $179K | Sell |
|
|||||
|
2021
Q1 | $315K | Sell |
|
|||||
|
2020
Q4 | $485K | Buy |
|
|||||
|
2020
Q3 | $149K | Buy |
|
|||||
|
2020
Q2 | $103K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $108K | Buy |
|
|||||
|
2019
Q1 | $5K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $337K | Buy |
|
|||||
|
2017
Q4 | $332K | Buy |
|
|||||
|
2017
Q3 | $467K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $27K | Sell |
|
|||||
|
2016
Q4 | $106K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $46K | Buy |
|
|||||
|
2016
Q1 | – | Hold |
|
|||||
|
2015
Q4 | – | Hold |
|